Literature DB >> 20838279

Determinants of long-term graft outcome in transplant glomerulopathy.

Rohan John1, Ana Konvalinka, Ana Tobar, Sang J Kim, Heather N Reich, Andrew M Herzenberg.   

Abstract

BACKGROUND: Transplant glomerulopathy (TG) is a renal allograft disease defined by glomerular basement membrane duplication with peritubular capillary basement membrane multilayering (PTCML), and associated with anti-human leukocyte antigen antibodies and C4d. Outcome in TG is poor but variable, and prognostic factors, particularly those affecting long-term outcome, are not well known. We investigated several potentially prognostic clinical and pathologic factors in TG and evaluated estimated glomerular filtration rate (eGFR) slopes to assess graft function and early decline.
METHODS: We examined all cases of TG from 2001 to 2005 with at least 4-year follow-up after biopsy, excluding those with a second confounding diagnosis.
RESULTS: Among 36 cases of pure TG, mean graft age at biopsy was 8.8±6 years. C4d stain was positive in 11 (33%) cases. Clinical characteristics at biopsy were not different based on C4d. C4d was associated with greater PTCML (P=0.03), peritubular capillaritis (P=0.04), and glomerulitis (P=0.03). Death-censored graft survival was significantly associated with interstitial fibrosis (P=0.001), PTCML (P=0.001), and arteriolar hyalinosis (P=0.007), and it showed a trend with proteinuria (P=0.07) and C4d positivity (P=0.08). C4d-positive cases also showed a trend toward rapid graft loss. Analysis of eGFR slopes showed a pattern of preserved, slightly negative slope from transplant until approximately 1 year before biopsy, at which point the slope became significantly more negative (P<0.001).
CONCLUSION: Interstitial fibrosis, PTCML, and arteriolar hyalinosis were significant predictors of graft survival in TG. C4d positivity was associated with a more rapid rate of function decline. eGFR slope data showed significant deterioration in graft function well before the diagnostic biopsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20838279     DOI: 10.1097/TP.0b013e3181efcffd

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Transplant glomerulopathy: the view from the other side of the basement membrane.

Authors:  Mark Haas
Journal:  J Am Soc Nephrol       Date:  2014-11-11       Impact factor: 10.121

2.  Renal graft biopsy assists diagnosis and treatment of renal allograft dysfunction after kidney transplantation: a report of 106 cases.

Authors:  Yong Han; Hui Guo; Ming Cai; Li Xiao; Qiang Wang; Xiaoguang Xu; Haiyan Huang; Bingyi Shi
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Acute and chronic antibody-mediated rejection in pediatric kidney transplantation.

Authors:  Lars Pape; Jan U Becker; Stephan Immenschuh; Thurid Ahlenstiel
Journal:  Pediatr Nephrol       Date:  2014-05-28       Impact factor: 3.714

4.  Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.

Authors:  Sergi Clotet-Freixas; Caitriona M McEvoy; Ihor Batruch; Chiara Pastrello; Max Kotlyar; Julie Anh Dung Van; Madhurangi Arambewela; Alex Boshart; Sofia Farkona; Yun Niu; Yanhong Li; Olusegun Famure; Andrea Bozovic; Vathany Kulasingam; Peixuen Chen; S Joseph Kim; Emilie Chan; Sajad Moshkelgosha; Syed Ashiqur Rahman; Jishnu Das; Tereza Martinu; Stephen Juvet; Igor Jurisica; Andrzej Chruscinski; Rohan John; Ana Konvalinka
Journal:  J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 10.121

Review 5.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

6.  Donor-specific Antibody Surveillance and Graft Outcomes in Pediatric Kidney Transplant Recipients.

Authors:  Rachel M Engen; Giulia E Park; Cooper S Schumacher; Idoia Gimferrer; Paul Warner; Laura S Finn; Noel S Weiss; Jodi M Smith
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

7.  Urinary vitronectin identifies patients with high levels of fibrosis in kidney grafts.

Authors:  Laura Carreras-Planella; David Cucchiari; Laura Cañas; Javier Juega; Marcella Franquesa; Josep Bonet; Ignacio Revuelta; Fritz Diekmann; Omar Taco; Ricardo Lauzurica; Francesc Enric Borràs
Journal:  J Nephrol       Date:  2020-12-04       Impact factor: 3.902

8.  Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation.

Authors:  Qiquan Sun; Xianghua Huang; Song Jiang; Caihong Zeng; Zhihong Liu
Journal:  BMC Nephrol       Date:  2012-09-28       Impact factor: 2.388

9.  Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy.

Authors:  Qiang Zhang; Klemens Budde; Danilo Schmidt; Fabian Halleck; Michael Duerr; Marcel G Naik; Manuel Mayrdorfer; Wiebke Duettmann; Frederick Klauschen; Birgit Rudolph; Kaiyin Wu
Journal:  Front Med (Lausanne)       Date:  2021-07-02

Review 10.  Transplant glomerulopathy: the interaction of HLA antibodies and endothelium.

Authors:  William Hanf; Claudine S Bonder; P Toby H Coates
Journal:  J Immunol Res       Date:  2014-03-09       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.